ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

FHTX Foghorn Therapeutics Inc

5.73
0.00 (0.00%)
Pre Market
Last Updated: 18:17:05
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Foghorn Therapeutics Inc FHTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 5.73 18:17:05
Open Price Low Price High Price Close Price Previous Close
5.73
more quote information »

Recent News

Date Time Source Heading
07/3/202423:11EDGAR2Form 8-K - Current report
07/3/202423:09EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/2/202423:04EDGAR2Form 8-K - Current report
26/1/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202408:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202408:09EDGAR2Form 8-K - Current report
08/1/202423:04EDGAR2Form 8-K - Current report
04/1/202408:18EDGAR2Form 8-K - Current report
28/11/202311:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21/11/202322:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
02/11/202322:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202322:03EDGAR2Form 8-K - Current report
02/11/202301:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
11/9/202320:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
08/9/202321:04EDGAR2Form 8-K - Current report
05/9/202322:00GLOBEFoghorn Therapeutics Announces Participation in Upcoming..
31/8/202321:04EDGAR2Form 8-K - Current report
31/8/202321:00GLOBEFoghorn Therapeutics Announces First Patient Dosed in Phase..
29/8/202323:00PRNUSInvaio achieves first registration for citrus greening..
19/8/202306:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202306:08EDGAR2Form 8-K - Current report
08/8/202321:05EDGAR2Form 8-K - Current report
08/8/202321:00GLOBEFoghorn Therapeutics Announces Chief Medical Officer..
04/8/202321:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202321:05EDGAR2Form 8-K - Current report
04/8/202321:00GLOBEFoghorn Therapeutics Provides Second Quarter 2023 Financial..
28/6/202321:00GLOBEFoghorn Therapeutics Announces Clinical Data from Phase 1..
05/6/202322:07DJNFoghorn Therapeutics Shares Rally Premarket as FDA Lifts..
16/5/202320:00PRNUSFlagship Pioneering Launches Metaphore Biotechnologies to..

Your Recent History

Delayed Upgrade Clock